Overall, the aforementioned data revealed a previously undefined role of SENP6 and indicated that inhibiting the activity of SENP6 or its binding with Nrf2 would be a novel and promising therapeutic strategy for ischemic stroke and possibly other neurological disorders characterized by oxidative stress manifestations. This evidence concerns the gene NFE2L2 and nervous system disorder.